37. Generalised pustular psoriasis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 79 / Drugs : 57 - (DrugBank : 21) / Drug target genes : 20 - Drug target pathways : 102
Generalised pustular psoriasis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
37 | Generalised pustular psoriasis |
49 | Systemic lupus erythematosus |
13 | Multiple sclerosis/Neuromyelitis optica |
97 | Ulcerative colitis |
46 | Malignant rheumatoid arthritis |
53 | Sjogren syndrome |
65 | Primary immunodeficiency |
41 | Giant cell arteritis |
96 | Crohn disease |
160 | Congenital ichthyosis |
56 | Behcet disease |
50 | Dermatomyositis |
84 | Sarcoidosis |
162 | Pemphigoid |
269 | Pyogenic arthritis |
271 | Ankylosing spondylitis |
202 | Smith-Magenis syndrome |
75 | Cushing disease |
107 | Juvenile idiopathic arthritis |
299 | Cystic fibrosis |
2 | Amyotrophic lateral sclerosis |
40 | Takayasu arteritis |
39 | Toxic epidermal necrolysis |
15 | Inclusion body myositis |
106 | Cryopyrin-associated periodic syndrome |
90 | Retinitis pigmentosa |
36 | Epidermolysis bullosa |